C4 Therapeutics, Inc. CCCC
$3.39
-0.73%
at last close
Financials (TTM)
- Revenue
- $35.04 million
- Net Income
- $-101,416,000
- Net Margin
- -289.44%
- Return on Equity
- -41.02%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.69
- Price / Sales
- 11.90
Over the trailing twelve months, C4 Therapeutics, Inc. generated revenue of $35.04 million and net income of $-101,416,000, a net margin of -289.44%.
At the last closing price of $3.39, CCCC trades at 11.90 times sales, with a market capitalization of $417.06 million.
Key Stats
- Last Close
- $3.39
- Market Cap
- $417.06 million
- 52-Week Range
- $1.69 – $5.17
- Average Volume
- 2.14 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.